Stay updated on RC48-ADC in Advanced Melanoma HER2 Variant Clinical Trial
Sign up to get notified when there's something new on the RC48-ADC in Advanced Melanoma HER2 Variant Clinical Trial page.

Latest updates to the RC48-ADC in Advanced Melanoma HER2 Variant Clinical Trial page
- CheckyesterdayChange DetectedThe web page has undergone significant changes, including the addition of a facility name and location details, while several location-related terms have been removed.SummaryDifference8%
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe web page has been updated from version v2.16.11 to v2.16.12.SummaryDifference0.3%
- Check23 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.3%
- Check30 days agoChange DetectedThe web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.SummaryDifference4%
- Check37 days agoChange DetectedThe web page has updated its version from v2.16.6 to v2.16.8 and added a section on HHS Vulnerability Disclosure.SummaryDifference0.8%
- Check44 days agoChange DetectedThe web page has been updated to reflect a planned maintenance alert starting July 25th, during which most services will be unavailable for over 24 hours. Additionally, the version has been updated from v2.16.5 to v2.16.6.SummaryDifference4%
Stay in the know with updates to RC48-ADC in Advanced Melanoma HER2 Variant Clinical Trial
Enter your email address, and we'll notify you when there's something new on the RC48-ADC in Advanced Melanoma HER2 Variant Clinical Trial page.